At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,000 enrolled
Drug / intervention
Toviaz treatmentdrug
Likely dose
Toviaz treatment 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)
In Brief
An observational study evaluating Toviaz treatment for Overactive Bladder. Completed, enrolled 3,000 participants across 82 sites.
Detailed Summary
The objective of this study is to determine the problems and questions of safety and efficacy of Toviaz® under the standard conditions of usage.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartNov 2009
Primary CompletionAug 2014
TodayJul 2026
First PostedApr 10, 2009
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 17.2 years ago
Interventions
Toviaz treatmentdrug
4 mg starting then can be followed by 8 mg